Omega Healthcare Investors Inc. (OHI) Dividend Safety Gauge & 10-Year DRIP Compounder

OHI scores 66 out of 100, a C+ grade labeled "Roarable Hold — Upper Neutral / Watch for Breakout." The five pillars break down as follows. Fundamental Cash Engine scores 14 of 20, with ROIC at 0% and an FCF yield of 5.81%, indicating that cash generation is strong relative to the share price while reported returns on invested capital are negligible. Whale 13F Flow scores 12 of 20, reflecting institutional accumulation and options positioning that is supportive but not dominant. Insider Conviction scores 13 of 20, based on SEC Form 4 and Congressional PTR cluster flow. Macro Regime Fit scores 12 of 20, with a beta of 1.08 and sector sensitivity that places the stock modestly more volatile than the market. Forensic Balance Sheet scores 15 of 20, the strongest pillar, supported by an Altman Z-Score of 2.5, a Piotroski F-Score of 9 of 9, and a Debt/Equity ratio of 0.5.

For a prospective investor evaluating the stock today, the upside drivers visible in these facts are the cash-flow yield, the clean forensic profile, and the stock's position near the upper portion of its 52-week range while the rating labels it as a candidate for a breakout. The principal valuation tradeoff is that the reported EV/EBITDA of 95 and the near-zero ROIC and margins sit uneasily against the dividend yield of 5.5% and the FCF yield; the investor must weigh whether reported cash flow reflects durable earnings power or is distorted by items that do not appear in the earnings line. The rating does not resolve this, and the verdict language should be read as an analytical classification, not a recommendation.

Omega Healthcare Investors Inc. (OHI) is a NYSE-listed issuer in the Financials sector, within the Real Estate Investment Trusts industry. Reported revenue of $1.

Revenue grew from $949.7M in FY 2023 to $1.19B in FY 2025, while reported operating income and net income remained below $1M in each period, consistent with the 0.1% operating and net margins in the market data and the 0% gross margin. ROIC is 0%. The Altman Z-Score of 2.5 and Piotroski F-Score of 9 of 9 are reported in the forensic balance sheet pillar, and Debt/Equity is 0.5. Reported debt declined from $2.33B in FY 2024 to $2.07B in FY 2025, while cash fell from $518.3M to $27.0M over the same period.

• 🐂 Primary Bull Case: Strong free cash flow ($825.0M in FY 2025) and a 5.5% dividend yield, backed by a perfect 9 of 9 Piotroski F-Score and a 0.5 Debt/Equity ratio. With Fundamental Cash Engine at 14/20 (ROIC 0.0%, FCF yield 5.81%) and Institutional Whale Flow at 12/20, sustained execution supports upside toward the top of the $40.86 – $52.39 52-week range.
• 🐻 Primary Bear Case: Reported operating and net income were under $1M in FY 2025 against a $90 Million Florida facility transfer expense, with ROIC at 0% and EV/EBITDA at 95. Investors must weigh current valuation and 95.0x EV/EBITDA against 0.1% operating margins and a 1.08 macro beta if sector demand softens.

Operating in Real Estate Investment Trusts (Financials), OHI carries a macro regime beta of 1.08 and gross margin of —.

• Key Question #1: What is the explanation for the $90 Million expense associated with the Florida facility transfer, and how does it affect reported earnings and cash flow?
• Key Question #2: Why does reported EV/EBITDA of 95 coexist with a 5.5% dividend yield and near-zero margins, and which earnings measure best reflects distributable cash?
• Key Question #3: What is the composition of the reported debt and whether the decline from $2.33B to $2.07B reflects scheduled repayment or refinancing?